Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is …
Biotechnology
CA, Burnaby [HQ]
Ratios
13 Sheets · Starting from 2023Margins, Growth Rates In %
| Ratio | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||
| Gross Margin | 100.00 | 48.84 | 77.30 | 79.19 | 82.27 | 38.21 | -8,122.83 | - - | -468.82 | -57.07 | -309.30 | -1,021.13 | - - | |
| Profit Margin | -173.34 | -30.06 | 43.98 | 45.89 | -101.12 | -1,275.49 | -9,872.67 | - - | -609.09 | -89.65 | -427.85 | -1,328.95 | - - | |
| Operating Margin | -175.11 | -22.04 | 35.50 | 39.15 | -60.10 | -1,376.43 | -10,474.28 | - - | -627.02 | -97.31 | -428.45 | -1,368.91 | - - | |
|
EPS Growth
|
- - | 64.39 | 189.36 | 878.57 | -126.76 | -34.55 | -15.54 | -4.09 | 10.11 | 48.13 | -118.07 | -14.37 | -31.88 | |
| EPS USD | -132.00 | -47.00 | 42.00 | 411.00 | -110.00 | -148.00 | -171.00 | -178.00 | -160.00 | -83.00 | -181.00 | -207.00 | -273.00 | |
| Return on Assets (ROA) | - - | -6.79 | 22.08 | 14.89 | -24.63 | -34.08 | -66.57 | -28.18 | -28.16 | -15.24 | -13.79 | -16.62 | -18.90 | |
| Return on Equity (ROE) | - - | -34.07 | 49.89 | 17.89 | -25.81 | -35.99 | -85.45 | -33.40 | -45.22 | -16.83 | -14.34 | -17.38 | -19.66 | |
| Return on Invested Capital (ROIC) | - - | -22.54 | 40.06 | 15.26 | -14.33 | -35.76 | -71.58 | -32.58 | -39.47 | -17.76 | -14.15 | -17.66 | -22.76 | |
| Solvency | ||||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | - - | 2.63 | - - | - - | - - | - - | 14.75 | 24.53 | 11.14 | 1.75 | 1.44 | 1.38 | 1.13 | |
| Debt/Equity | - - | 13.19 | - - | - - | - - | - - | 18.94 | 29.07 | 17.89 | 1.94 | 1.50 | 1.45 | 1.18 | |
| Debt/EBITDA | - - | 2,631.44 | -352.86 | -580.29 | 626.55 | 67.65 | 41.06 | 145.63 | 20.74 | 133.20 | 211.96 | 36.24 | 65.43 | |
|
Debt/Capitalization
|
- - | 11.65 | - - | - - | - - | - - | 15.92 | 22.52 | 15.17 | 1.90 | 1.48 | 1.43 | 1.16 | |
| Long-Term Debt/Capitalization | - - | 11.65 | - - | - - | - - | - - | 14.52 | 12.69 | 11.23 | 1.75 | 1.37 | 1.36 | 1.02 | |
| Interest Debt per Share USD | - - | 0.19 | 0.01 | - - | - - | - - | 0.38 | 1.62 | 0.69 | 0.11 | 0.19 | 0.08 | 0.16 | |
| Debt Growth | - - | - - | -100.00 | - - | - - | - - | - - | 120.66 | 9.56 | -79.85 | 149.08 | 26.38 | 4.49 | |
| Liquidity | ||||||||||||||
| Current Ratio | - - | 316.23 | 273.96 | 594.58 | 2,187.85 | 1,867.89 | 1,097.75 | 2,948.22 | 333.95 | 1,229.84 | 3,903.23 | 2,644.25 | 2,364.84 | |
| Quick Ratio | - - | 315.45 | 273.12 | 589.78 | 2,119.55 | 1,830.09 | 1,080.21 | 2,902.69 | 327.74 | 1,209.79 | 3,871.94 | 2,612.43 | 2,342.82 | |
| Cash Ratio | - - | 313.41 | 208.48 | 504.17 | 2,108.23 | 486.21 | 501.74 | 1,644.91 | 57.07 | 304.51 | 1,226.70 | 252.15 | 545.02 | |
| Operating Cash Flow Ratio | - - | 200 | - - | - - | -600 | -500 | -700 | -800 | - - | -300 | -400 | -400 | -500 | |
| Turnover | ||||||||||||||
| Inventory Turnover | - - | - - | - - | - - | -876.83 | - - | - - | - - | - - | -2,772.94 | -2,729.22 | -10,726.88 | - - | |
| Receivables Turnover | - - | 3,650.00 | 6,217.27 | 13,195.35 | 4,945.08 | 901.50 | 71.01 | - - | 839.98 | 1,765.42 | 666.80 | 956.80 | - - | |
| Payables Turnover | - - | 891.60 | 1,588.24 | 1,067.45 | 253.86 | 76.15 | 2,040.94 | 902.26 | 1,570.76 | 1,661.39 | 1,973.41 | 1,245.64 | 41.18 | |
|
Asset Turnover
|
- - | 22.60 | 50.21 | 32.45 | 24.36 | 2.67 | 0.67 | - - | 4.62 | 17.00 | 3.22 | 1.25 | - - | |
| Fixed Turnover | - - | 549.88 | 1,455.88 | 1,145.80 | 783.16 | 128.42 | 29.07 | - - | 263.36 | 467.53 | 147.24 | 55.80 | - - | |
| Coverage | ||||||||||||||
| Interest Coverage | -13,312.09 | -3,390.32 | 15,175.00 | - - | - - | - - | - - | -2,727.12 | -2,985.98 | -6,467.15 | - - | 2,342.94 | - - | |
| Asset Coverage | - - | 2,600 | - - | - - | - - | - - | 600 | 800 | 600 | 5,200 | 6,700 | 7,000 | 8,600 | |
| Cash Flow Coverage (CFGR) | - - | 2,737.12 | - - | - - | - - | - - | -422.19 | -115.64 | -28.16 | -1,451.70 | -841.73 | -943.27 | -1,332.91 | |
| EBITDA Coverage | -11,900 | -2,300 | 16,800 | - - | - - | - - | - - | -2,500 | -2,700 | -6,400 | - - | 2,300 | - - | |
| Dividend Coverage | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | - - | - - | 100 | 100 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Market Prospects | ||||||||||||||
| Dividend Yield | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Earnings Yield | -12.58 | -4.51 | 12.61 | 20.82 | -13.72 | -19.28 | -60.33 | -28.14 | -12.23 | -5.43 | -5.79 | -5.25 | -5.92 | |
|
Price/Earnings (P/E)
|
-794.67 | -2,217.94 | 792.83 | 480.26 | -728.96 | -518.76 | -165.77 | -355.32 | -817.56 | -1,842.28 | -1,727.80 | -1,904.06 | -1,689.16 | |
| Price/Earnings Growth (PEG) | - - | 34.44 | -4.19 | 0.55 | 5.75 | -15.02 | -10.67 | -86.80 | 80.85 | 38.28 | -14.63 | -132.55 | -52.98 | |
|
Price/Book (P/B)
|
- - | 755.71 | 395.56 | 85.90 | 188.13 | 186.69 | 141.64 | 118.67 | 369.73 | 310.03 | 247.79 | 330.86 | 332.02 | |
| Price/Tangible Book (P/TB) | - - | 755.71 | 395.56 | 85.90 | 188.13 | 186.69 | 141.64 | 118.67 | 369.73 | 310.03 | 247.79 | 330.86 | 332.02 | |
| Price/Sales (P/S) | 1,377.52 | 666.72 | 348.71 | 220.37 | 737.15 | 6,616.74 | 16,365.83 | - - | 4,979.73 | 1,651.62 | 7,392.32 | 25,303.97 | - - | |
|
Price/Cash Flow (P/CF)
|
-696.15 | 209.32 | -2,871.57 | 23,503.78 | -634.29 | -609.70 | -177.18 | -353.00 | -7,341.66 | -1,103.94 | -1,960.98 | -2,425.25 | -2,119.98 | |
| Price/Free CF (P/FCF) | -681.71 | 211.76 | -2,742.78 | -4,950.12 | -615.56 | -601.13 | -175.26 | -347.92 | -5,791.31 | -1,046.59 | -1,904.80 | -2,355.98 | -2,041.09 | |
| Price/Operating CF (P/OCF) | -696.15 | 209.32 | -2,871.57 | 23,503.78 | -634.29 | -609.70 | -177.18 | -353.00 | -7,341.66 | -1,103.94 | -1,960.98 | -2,425.25 | -2,119.98 |